BRIEF

on AI/ML Innovations Inc. (CVE:AIML)

AIML's NeuralCloud and Toronto Heart Centre Test AI-Enhanced Holter ECG Reporting

AI/ML Innovations Inc. has announced a collaborative pilot program between its subsidiary, NeuralCloud Solutions, and the Toronto Heart Centre. The initiative will assess the efficacy of CardioYield™, an AI-powered Holter ECG analysis and reporting tool.

CardioYield™ utilizes MaxYield™, a signal-processing platform, to improve report turnaround times and technician efficiency at the Toronto Heart Centre. This facility, comprising over 20 cardiologists, offers advanced cardiovascular services in the community.

The study involves direct comparisons with current industry-standard software, focusing on time savings, throughput, and analysis quality. The outcome aims to showcase the potential of AI to enhance diagnostic reliability and workflow efficiency in clinical settings.

Experts from both parties, including Dr. Chi Ming Chow and Paul Duffy, express optimism about the program's ability to transform Holter data processing. This partnership highlights an important step in leveraging AI for improved healthcare outcomes.

R. H.

Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all AI/ML Innovations Inc. news